Pharmacological blockade of group II metabotropic glutamate receptors reduces the growth of glioma cells in vivo-Reference-Cited by-同舟云学术

Pharmacological blockade of group II metabotropic glutamate receptors reduces the growth of glioma cells in vivo

Published:2005-07-01 Issue:3 Volume:7 Page:236-245
ISSN:1523-5866
Container-title:Neuro-Oncology
language:en
Short-container-title:

Author:

Arcella Antonietta,Carpinelli Giulia,Battaglia Giuseppe,D'Onofrio Mara,Santoro Filippo,Ngomba Richard Teke,Bruno Valeria,Casolini Paola,Giangaspero Felice,Nicoletti Ferdinando

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Clinical Neurology,Oncology

Link

http://academic.oup.com/neuro-oncology/article-pdf/7/3/236/13066199/NO007-03_03Arcella.pdf

Reference28 articles.

1. Aronica, E., Gorter, J.A., Ijlst-Keizers, H., Rozemuller, A.J., Yankaya, B., Leenstra, S., and Troost, D. (2003) Expression and functional role of mGluR3 and mGluR5 in human astrocytes and glioma cells: Opposite regulation of glutamate transporter proteins. Eur. J. Neurosci.17,2106 -2118.

2. Battaglia, G., Bruno, V., Ngomba, R.T., Di Grezia, R., Copani, A., and Nico letti, F. (1998) Selective activation of group-II metabotropic glutamate receptors is protective against excitotoxic neuronal death. Eur. J. Pharmacol.356,271 -274.

3. Bowman, C.L., Yohe, L., and Lohr, J.W. (1999) Enzymatic modulation of cell volume in C6 glioma cells. Glia27,22 -31.

4. Bredel, M., and Zentner, J. (2002) Brain-tumour drug resistance: The bare essentials. Lancet Oncol.3, 397-406.

5. Bruno, V., Battaglia, G., Copani, A., D'Onofrio, M., Di Iorio, P., De Blasi, A., Melchiorri, D., Flor, P.J., and Nicoletti F. (2001) Metabotropic glutamate receptor subtypes as targets for neuroprotective drugs. J. Cereb. Blood Flow Metab.21,1013 -1033.

Cited by 98 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metabotropic Glutamate Receptors Type 3 and 5 Feature the “NeuroTransmitter-type” of Glioblastoma: A Bioinformatic Approach;Current Neuropharmacology;2024-09

2. Molecular mechanisms of Tetrastigma hemsleyanum Diels&Gilg against lung squamous cell carcinoma: From computational biology and experimental validation;Journal of Ethnopharmacology;2024-09

3. A glutamatergic biomarker panel enables differentiating Grade 4 gliomas/astrocytomas from brain metastases;Frontiers in Oncology;2024-05-21

4. Neurotransmitters: promising immune modulators in the tumor microenvironment;Frontiers in Immunology;2023-05-05

5. A phase I trial of riluzole and sorafenib in patients with advanced solid tumors: CTEP #8850;Oncotarget;2023-04-10